COVID-19
Top Ten most popular articles on Pharmafile.com this week
April 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10
Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …
Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days
April 17, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir
The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …
New Chinese study shows Hydroxychloroquine does not speed up COVID-19 recovery
April 16, 2020Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine
The anti-malaria drug hydroxychloroquine does not speed up recovery from COVID-19, according to a new Chinese study. The study was …
Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain
April 16, 2020Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …
Intermittent social distancing could last until 2022, according to a new study
April 16, 2020Business Services COVID, COVID-19, coronavirus, social distancing
Social distancing that has been put in place to stem the spread of COVID-19 coronavirus could be implemented up until …
Pharmafile.com’s weekly COVID-19 news round-up
April 15, 2020Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine
Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, …
Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership
April 15, 2020Research and Development COVID-19, GSK, Sanofi, coronavirus
Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …
US to suspend funding of the World Health Organization amidst review
April 15, 2020Research and Development COVID, COVID-19, coronavirus
US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …
AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch
April 14, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma
As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …
Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients
April 14, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …
Fatal heart complications halt Brazilian study of chloroquine in treating COVID-19
April 14, 2020Manufacturing and Production COVID-19, chloroquine, hydroxychloroquine
A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons. It …
Pharmafile.com’s weekly COVID-19 news round-up
April 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus
The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
US reports increase in Hydroxychloroquine misuse
April 9, 2020Business Services COVID-19, Donald Trump, coronavirus, hydroxychloroquine
The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria …
COVID-19 less severe in paediatric patients, according to the CDC
April 8, 2020Research and Development COVID-19, coronavirus
The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …
Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers
April 8, 2020Research and Development COVID-19, coronavirus, covid 19, hydroxychloroquine
Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
